Iovance Biotherapeutics, Inc. (LON:0JDK)
2.320
0.00 (0.00%)
At close: Sep 17, 2025
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 838 employees as of December 31, 2024. The number of employees increased by 281 or 50.45% compared to the previous year.
Employees
838
Change (1Y)
281
Growth (1Y)
50.45%
Revenue / Employee
210.37K GBP
Profits / Employee
-339.62K GBP
Market Cap
587.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 838 | 281 | 50.45% |
Dec 31, 2023 | 557 | 54 | 10.74% |
Dec 31, 2022 | 503 | 184 | 57.68% |
Dec 31, 2021 | 319 | 78 | 32.37% |
Dec 31, 2020 | 241 | 93 | 62.84% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Iovance Biotherapeutics News
- 19 days ago - Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewsWire
- 23 days ago - Why Iovance Biotherapeutics Stock Got Mashed on Monday - The Motley Fool
- 26 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 27 days ago - Iovance Biotherapeutics: Tough Decisions Being Made But Catalysts In H2'25 - Seeking Alpha
- 4 weeks ago - Why Iovance Biotherapeutics Stock Was Climbing Today - The Motley Fool
- 4 weeks ago - Iovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma - GlobeNewsWire
- 5 weeks ago - Why Iovance Biotherapeutics Stock Plummeted Today - The Motley Fool
- 5 weeks ago - Iovance Biotherapeutics, Inc. (IOVA) Q2 2025 Earnings Call Transcript - Seeking Alpha